FoxO-1 contributes to the efficacy of the combination of...

  • Main
  • 2017 / 11
  • FoxO-1 contributes to the efficacy of the combination of...

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models

Corno, Cristina, Stucchi, Simone, De Cesare, Michelandrea, Carenini, Nives, Stamatakos, Serena, Ciusani, Emilio, Minoli, Lucia, Scanziani, Eugenio, Argueta, Christian, Landesman, Yosef, Zaffaroni, Nad
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Biochemical Pharmacology
DOI:
10.1016/j.bcp.2017.11.009
Date:
November, 2017
File:
PDF, 1.93 MB
english, 2017
Conversion to is in progress
Conversion to is failed